The European Patent Office (EPO) has published patent application EP4534045A1 concerning a novel graft and a method for its production. The application was filed by DSM IP Assets B.V. and lists CHENG, Wei, and LINSSEN, Marc as inventors. The publication date is March 11, 2026, and it falls under IPC classifications related to prosthetics (A61F).

This publication represents the grant of a patent, which confers exclusive rights to the applicant for their invention within the designated European states. While this is an intellectual property matter and not a direct regulatory mandate, it signifies a new technological development in the field of medical grafts. Companies operating in this sector should be aware of this patent for competitive intelligence and potential licensing or infringement considerations.